The present invention discloses a human
umbilical cord highly active
mesenchymal stem cell and a preparation method and application thereof. HA-MSCs are separated from human
umbilical cord tissue using TeSR-E8 containing 5% CloneR and LN521-Coated culture bottles, and a HA-MSC separation, amplification, and
cryopreservation technical
system is established. Compared with other separation methods, it is simpler and easier, and the time from the tissue being removed from the body to entering the
incubator is shorter, which largely maintains the
cell activity. The established
primary culture method enables the primitive cells or cells with strong pluripotency in the tissue to be sorted out from the primary generation, and can be stably passaged and preserved, providing a prerequisite for subsequent amplification. Compared with conventionally cultured MSCs, the HA-MSCs prepared by the present invention have higher
proliferation activity, smaller volume, higher nuclear-cytoplasmic ratio, and highly express
embryonic stem cell-related
marker antigens SOX2, Nanog, and OCT4, and have the potential to differentiate into neural, myocardial, and hepato-intestinal
progenitor cells derived from the three germ
layers.